CULTURED HUMAN ECTOCERVICAL EPITHELIAL-CELL DIFFERENTIATION IS REGULATED BY THE COMBINED DIRECT ACTIONS OF SEX STEROIDS, GLUCOCORTICOIDS, AND RETINOIDS

被引:35
作者
GORODESKI, GI
ECKERT, RL
UTIAN, WH
SHEEAN, L
RORKE, EA
机构
[1] CASE WESTERN RESERVE UNIV, SCH MED, DEPT ENVIRONM HLTH SCI, 2119 ABINGTON RD, CLEVELAND, OH 44106 USA
[2] CASE WESTERN RESERVE UNIV, SCH MED, DEPT PHYSIOL & BIOPHYS, CLEVELAND, OH 44106 USA
[3] MT SINAI MED CTR, DEPT OBSTET & GYNECOL, CLEVELAND, OH 44106 USA
关键词
D O I
10.1210/jcem-70-6-1624
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
During the menstrual cycle, the ectocervical epithelium undergoes a cyclic change in differentiation that is correlated with changes in the circulating levels of estrogens and progestins. To better understand the mechanisms underlying this regulation, we have developed an ectocervical epithelial cell (ECE cell) culture system that responds in a physiological manner to stimulation by estrogens and progestins. We have recently proposed that four classes of hormones (retinoids, estrogens, progestins, and glucocorticoids) may play an important role in regulating differentiation. In the present paper we test this hypothesis directly by making detailed dose-response curves. Our results demonstrate that estrogen increases ECE cell differentiation, as measured by release of cornified envelopes (superficial cells), while progesterone decreases envelope production. The effects are dose dependent and within the expected physiological range (0.01–10 nm estrogen; 0.1–100 nm progesterone). Very low concentrations of Ro 13–6298 (0.01–10 nm), a synthetic retinoid, decreased envelope production, while hydrocortisone (0.1–50 nm) increased envelope production and cell growth. Importantly, agents that enhance envelope production are neutralized by agents that reduce envelope formation and vice versa. Based on these findings we conclude 1) that the differentiation- enhancing actions of glucocorticoids and estrogens can be antagonized by either progestins or retinoids, and 2) that glucocorticoids and retinoids are likely to determine the ECE cell differentiation set-point in vivo, with the sex steroids directly modulating the phenotype of the ECE cells around this set-point during the menstrual cycle. Moreover, these results appear to explain some of the clinical descriptions of changes in ectocervical cell morphology resulting from hyper- and hypoestrogenic stimulation. © 1990 by The Endocrine Society.
引用
收藏
页码:1624 / 1630
页数:7
相关论文
共 38 条
[1]  
BONDY P K, 1985, P816
[2]  
BRENNAN JK, 1975, IN VITRO CELL DEV B, V11, P354, DOI 10.1007/BF02616371
[3]  
BRIAND P, 1984, CANCER RES, V44, P1114
[4]  
CLINE PR, 1983, CANCER RES, V43, P3203
[5]  
DELUCA LM, 1978, HDB LIPID RES, V2, P1
[6]   MOLECULAR-BIOLOGY OF KERATINOCYTE DIFFERENTIATION [J].
ECKERT, RL ;
RORKE, EA .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1989, 80 :109-116
[7]  
ECKERT RL, 1982, CANCER RES, V42, P139
[8]   HUMAN ENDOMETRIAL CELLS IN PRIMARY TISSUE-CULTURE - MODULATION OF THE PROGESTERONE-RECEPTOR LEVEL BY NATURAL AND SYNTHETIC ESTROGENS INVITRO [J].
ECKERT, RL ;
KATZENELLENBOGEN, BS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1981, 52 (04) :699-708
[9]   CLONING OF CDNAS SPECIFYING VITAMIN-A-RESPONSIVE HUMAN KERATINS [J].
ECKERT, RL ;
GREEN, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (14) :4321-4325
[10]   RETINOIDS, CANCER, AND THE SKIN [J].
ELIAS, PM ;
WILLIAMS, ML .
ARCHIVES OF DERMATOLOGY, 1981, 117 (03) :160-180